PerspectiveGet some perspective on valuation posibilities for VLNS.
JWEL (Jamieson Wellness "vitamins") trades on TSX.
Trading over 1 billion market cap with 80M+ expected in ebitda. (VLNS has 324M MKT CAP).
VLNS could conceiveably hit 80M in ebitda this year; and with a high probability it will do so in 2021. It is likely that VLNS in 2 years will dwarf JWEL in ebitda.
So whether a triple is possible is irrelevant, but what is important here is to highlight a strong buy at $2.30.